Amgen’s Blincyto (blinatumomab) has been approved by the European Commission (EC) to treat certain acute lymphoblastic ...

The National Institute for Health and Care Excellence (NICE) has approved Vertex Pharmaceuticals’ Casgevy (exagamglogene ...

Scientists from the Institute of Cancer Research (ICR) have found a new method for predicting bowel cancer risk in ...

With a menu featuring everything from cutting-edge science to DEI and diet, ASH 2024 certainly offered congress attendees ...